Commitments and Contingencies (Details Narrative) - USD ($) |
3 Months Ended | 12 Months Ended | |||||||
---|---|---|---|---|---|---|---|---|---|
Nov. 02, 2019 |
Jul. 25, 2019 |
Jul. 19, 2019 |
Jun. 21, 2019 |
Apr. 02, 2019 |
Jan. 14, 2019 |
Mar. 31, 2020 |
Mar. 31, 2019 |
Dec. 31, 2019 |
|
Insurance coverage | $ 500,000 | ||||||||
Douglas Carrara [Member] | Severance Pay [Member] | |||||||||
Loss Contingency, Damages Sought, Value | 200,000 | ||||||||
Douglas Carrara [Member] | Attorneys' Fees [Member] | |||||||||
Payment of attorney' fees | 10,000 | ||||||||
Novotek Therapeutics Inc., and NovoTek Pharmaceuticals Limited [Member] | |||||||||
Loss Contingency, Damages Sought, Value | $ 1,551,562 | ||||||||
Neelima Varma and St.David's [Member] | |||||||||
Loss contingency, seeking description | On July 25, 2019, the Company was notified that on July 23, 2019, a complaint was filed by Neelima Varma, against the Company and St. David's Healthcare Partnership, L.P., LLP ("St. David's"), in the district court of Travis County, Texas, alleging, among other things, negligence, gross negligence and strict product liability, breach of express warranty, breach of implied warranty and fraudulent misrepresentation and omission, with respect to a medical device which the Company had sold through one its distributors to St. David's. Ms. Varma is seeking aggregate monetary relief from the Company and St. David's in excess of $1,000,000. | ||||||||
St.David's [Member] | |||||||||
Loss contingency, seeking excess value | $ 1,000,000 | ||||||||
ChubeWorkx [Member] | |||||||||
Royalty expenses | 13,816 | $ 31,284 | |||||||
Accrued royalty | $ 6,908 | $ 4,906 | |||||||
Advisory Board [Member] | |||||||||
Number of shares issued | $ 25,000 | ||||||||
Stock based compensation | $ 41,667 | ||||||||
Settlement Agreement [Member] | |||||||||
Loss Contingency, Damages Sought, Value | $ 500,000 | ||||||||
Settlement Agreement [Member] | Watts Action [Member] | |||||||||
Payment of attorney' fees | $ 200,000 | ||||||||
Settlement Agreement [Member] | Watts and Chan Action [Member] | |||||||||
Payment of attorney' fees | $ 325,000 | ||||||||
Settlement Agreement [Member] | ChubeWorkx [Member] | |||||||||
Percentage of royalty received | 5.00% | ||||||||
Percentage of royalty retain | 50.00% | ||||||||
Due to related parties owned | $ 549,609 | ||||||||
Settlement Agreement [Member] | ChubeWorkx [Member] | Royalty [Member] | |||||||||
Royalty revenue | $ 5,000,000 |
X | ||||||||||
- Definition Accrued royalty. No definition available.
|
X | ||||||||||
- Definition Loss contingency, seeking excess value. No definition available.
|
X | ||||||||||
- Definition Payment of attorney' fees. No definition available.
|
X | ||||||||||
- Definition Percentage Of Royalty Received. No definition available.
|
X | ||||||||||
- Definition Percentage Of Royalty Retain. No definition available.
|
X | ||||||||||
- Definition Amount of expense recognized from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments), awarded to key employees or individuals. Excludes amount related to plans that cover generally all employees (for example, but not limited to, qualified pension plans). No definition available.
|
X | ||||||||||
- Definition Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Describes the form and magnitude of the award the plaintiff seeks in the legal matter, which may include an unspecified amount of money. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The value (monetary amount) of the award the plaintiff seeks in the legal matter. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Liability for extension of life insurance coverage in instances where coverage under the plan would otherwise end. No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|